GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Change In Other Working Capital

ENCell Co (XKRX:456070) Change In Other Working Capital : ₩511 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Change In Other Working Capital?

ENCell Co's Change In Other Working Capital for the quarter that ended in Mar. 2025 was ₩511 Mil. It means ENCell Co's Other Working Capital increased by ₩511 Mil from Dec. 2024 to Mar. 2025 .

ENCell Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was ₩-195 Mil. It means ENCell Co's Other Working Capital declined by ₩195 Mil from Dec. 2023 to Dec. 2024 .


ENCell Co Change In Other Working Capital Historical Data

The historical data trend for ENCell Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co Change In Other Working Capital Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
16.15 700.27 -1,011.60 -374.40 -195.20

ENCell Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only - -185.69 - - 511.36

ENCell Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩511 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ENCell Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of ENCell Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


ENCell Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines